11C-JNJ-63779586

N/A

Report date: 2025/12/01 17:16:57

Base Information

Drug Name11C-JNJ-63779586

Drug Alias Name11C-JNJ-63779586

ClassificationRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionPositron-emission tomography enhancersBroad substrate specificity ATP-binding cassette transporter ABCG2 bindersP-glycoprotein 1 binders

TargetsBroad substrate specificity ATP-binding cassette transporter ABCG2P-glycoprotein 1

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesJohnson & Johnson

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJanssen Research & Development Llc

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A